Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) PEG Ratio: N/A (As of Jun. 30, 2026)


XTUN:SIPHA Societe des Industries Pharmaceutiques de Tunisie-S I PHA T XTUN:SIPHA
12 GF Score
Price TND4.01
! 1 Warning Sign
View Full Analysis

What is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PE Ratio without NRI is . Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's 5-Year EBITDA growth rate is 0.00%. Therefore, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PEG Ratio or its related term are showing as below:



XTUN:SIPHA's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.695
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T  (XTUN:SIPHA) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T PEG Ratio Related Terms


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T PEG Ratio Historical Data

* Premium members only.

The historical data trend for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T PEG Ratio Chart

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Annual Data
Trend
PEG Ratio

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Semi-Annual Data
PEG Ratio

XTUN:SIPHA vs BIEI, PTXTQ, INQD: PEG Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T PEG Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PEG Ratio falls into.


XTUN:SIPHA
12GF Score
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T XTUN:SIPHA
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Business Description

Address Fondouk Choucha, Ben Arous, TUN, 2013
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.
12GF Score

Get the complete analysis for XTUN:SIPHA

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

TND4.01
Price